Ars Technica
Elections 2026Hollywood / Ars Technica
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
6 Aug 2026 10:01 pm
27 C
Moderna's mRNA flu shot earns FDA approval after rollercoaster review
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.